A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients

Journal of Addictive Diseases

Volumn 22, Issue 2, 2003, Pages 49-61

  Margolin, Arthur ^a   Kantak, Kathleen ^b   Copenhaver, Michael ^a   Avants, S Kelly ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Cocaine; Magnesium; Methadone; Opiates

Indexed keywords

COCAINE; ILLICIT DRUG; MAGNESIUM ASPARTATE; METHADONE; OPIATE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; DRUG USE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; METHADONE TREATMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SIDE EFFECT; WITHDRAWAL SYNDROME;

ADULT; ASPARTIC ACID; COCAINE-RELATED DISORDERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; STREET DRUGS;

EID: 0037545959     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v22n02_04     Document Type: Article

References (35)

1. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: A review. Drug Alcohol Depend. 2000;59(1):17-31.
2. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs. high-dose methadone in the treatment of opioid dependence: A randomized trial. JAMA. 1999;281(11):1000-1005.
3. Margolin A, Kleber HD, Avants SK, et al. Acupuncture for the treatment of cocaine addiction. A randomized controlled trial. JAMA. 2002;287(1):55-63.
4. Boadle-Biber MC. Activation of tryptophan hydroxylase from central serotonergic neurons by calcium and depolarization. Biochemical Pharmacol. 1977;27:1069-1079.
5. Raese JD, Edelman AM, Makk G, et al. Brain striatal tyrosine hydroxylase: activation of the enzyme by cyclic AMP-independent phosphorylation. Comm Pharmacol. 1979;3:295-301.
6. Amejdki-Chab N, Benmansour S, Costentin J, Bonnet JJ. Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: Attempts to characterize the NA+ dependence of the neuronal transport of dopamine. J Neurochem. 1992;59:1795-1804.
7. Hendley ED, Whittemore SR, Chaffee JE, Ehrlick YH. Regulation of norepinephrine uptake by adenine nucleotides and divalent cations: Role for extracellular protein phosphorylation. J Neurochem. 1988;50:263-273.
8. White TD. A role of divalent cations in the uptake of noradrenaline by synaptosomes. J Neurochem. 1975;24:1037-1042.
9. 3H-Dopamine binding to rat striatal D-2 and D-3 sites: Enhancement by magnesium and inhibition by guanine nucleotides and sodium. Life Sci. 1982;30:1587-1595.
10. 1a serotonin receptor subtype in rat brain: Guanine nucleotide and divalent cation sensitivity. Mol Pharmacol. 1985;28:487-494.
11. Pasternak GW, Snowman AM, Snyder SH. Selective enhancement of [3H]opiate agonist binding by divalent cations. Mol Pharmacol. 1975; 11:735-744.
12. Wong EHF, Kemp JA. Sites for antagonism of the N-methyl-D-aspartate receptor channel complex. Annu Rev Pharmacol Toxicol. 1991;31:401-425.
13. Kantak KM, Lawley SI, Wasserman SJ, Bourg JF. Magnesium-maintained self-administration responding in cocaine-trained rats. Psychopharmacol. 1991;104:527-535.
14. Kantak KM, Bourg JF, Lawley SI. Failure of magnesium to maintain self-administration in cocaine-naive rats. Pharmacol Biochem Behav. 1990;36:9-12.
15. 2 on responding maintained by cocaine, extinction from cocaine, glucose+saccharin, and food. Pharmacol Biochem Behav. 1992;41:415-423.
16. Lawley SI, Kantak KM. Post-conditioning effects of magnesium on cocaine induced place preference in mice. Pharmacol Biochem Behav. 1990;36:531-538.
17. Lawley SI, Kantak KM. Magnesium induced place preference in mice. Pharmacol Biochem Behav. 1990;36:39-545.
18. Kantak KM, Edwards MA, Spealman RD. Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists. J Pharmacol Exp Ther. 1995;274:657-665.
19. Kantak KM, Edwards MA, Wilcox KM, Kitchel E. Discriminative stimulus effects of magnesium chloride: substitution studies with monoamine uptake inhibitors and N-methyl-D aspartate antagonists. J Pharmacol Exp Ther. 1997;283:200-206.
20. McCarthy RJ, Kroin JS, Tuman KJ, et al. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats. Anesth Analg. 1998;86:830-836.
21. Kroin JS, McCarthy RJ, VonRoenn N, et al. Magnesium sulfate potentiates morphine antinociception at the spinal level. Anesth Analg. 2000;90:913-917.
22. Teichmann J, Stephan E, Lange U, et al. Elevated serum-calcium and parathormone-levels in HIV afflicted female heroin addicts. Eur J Med Res. 1997;2(8):343-346.
23. Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions: Preventive and therapeutic implications. J Am Coll Nutr. 1994;13(5):429-446.
24. First M, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P -Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute, 722 W. 168th Street, New York, NY 10032; 1996.
25. Littlefield NA, Hass BS. Is the RDA for magnesium too low? Abstract No. C-13. Paper presented at: FDA Science Forum, 1996; Washington, DC.
26. Lima M, Cruz T. Pousada JC, Rodrigues LE, et al The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998;21(5):682-686.
27. Weiss GB, Traina VM, Douglas FL. Magnesium aspartate hydrochloride. In: Scriabine A, ed. New cardiovascular drugs. NY: Raven Press; 1986:243-257.
28. 2+ and other divalent cations on the binding of tritiated opioid ligands. J Neurochem. 1992;59:467-472.
29. 3H]spiroperidol binding associated with dopamine receptors of rat brain. J Neurochem. 1980;34:669-676.
30. Gorman AL, Elliott KJ, Inturrisi CE. The d-and 1-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223:5-8.
31. Bilsky EJ, Inturrisi CE, Sadee W, et al. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain. 1996(68):229-237.
32. Elliott KJ, Hynansky A, Inturrisi CE. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain. 1994;59:361-368.
33. Golf SW, Riediger H, Matthes S, et al. Homeostasis of magnesium in man after oral supplementation: Results of a placebo controlled blind study. Mag-Bull. 1990;12(4):144-148.
34. McLean RM. Magnesium and its therapeutic uses. A Review. Am J Med. 1994;96(1):63-76.
35. Haigney MC, Silver B, Tanglao E, et al. Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation. 1995;92(8):2190-2197.